What they produce:
Copied from Google Finance.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. In August 2013, Abbott Laboratories completed its acquisition of OptiMedica Corporation. In August 2013, Abbott Laboratories completed its acquisition of IDEV Technologies.
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a good investment. Even for today, this stock has went from $41.44 to $41.59. This company doesn't have many decreases, the charts all go positive and the business is growing. The company has a good set of business people to run the business and make responsible money making not wasting decisions. Personally, I would recommend this stock to investors looking to have a nice pay day someday in the future when this business gains more capitol. Actavis
Information found at Actavis website.
Actavis is a pharmaceutical company that produces drugs. Mostly Generic brands of drugs, but their a major medicine supplier in our country.
This company does not pay dividends.
Information from Google finance.
52 Week High/Low:
$136.52 - $249.94
My Recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a sketchy investment. This is one of those stock that are either doing great and your making money, and the next day the price drops $5.00 a share. It all really depends on health in our country, more sick people, more medicine needed, less sick people, less medicine needed. Alcoa
What they produce:
Alcoa Inc. (Alcoa) is engaged in lightweight metals, products and solutions. The Company offers its technology and expertise in automotive and aerospace transportation, building and construction, consumer electronics and packaging, defense applications across air, land and sea, and the oil and gas industry. The Company is also a producer of primary aluminum, as well as a miner of bauxite and refiner of alumina. The Company’s segments include Alumina, Primary Metals, Global Rolled Products and Engineered Products and Solutions.
Copied from website.
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a sketchy investment. This stock is not really steady, it has its time where all it does is positively go up and you can make a bunch of money, but the next day its down back to $8.00 a share. Its not consistent enough for me to invest in anyway. Allergan
What they Produce:
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company’s segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and other prescription and over-the-counter skin care products; and urologic products and the medical devices segment, which produces a range of medical devices, including breast implants for augmentation, revision and reconstructive surgery and tissue expanders; obesity intervention products, and facial aesthetics products. In April 2014, TauTona Group’s subsidiary Aline Aesthetics has completed the sale of its Aline hyaluronic acid (HA) thread technology to Allergan, Inc.
Copied from Website.
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a pretty good investment but not at this moment. The stock history isnt to bad, the 52 week high/low is $88.34 all the way up to $192.98. Thats a good increase for one year, over one hundred dollars. But at the moment the stock isnt looking so good so its best to watch the stock and wait for it, hitting it at the right time for a sure investment. American Tower Corporation
What they Produce:
American Tower Corporation is a holding company. The Company conducts its operations through its directly and indirectly owned subsidiaries and joint ventures. It is a wireless and broadcast communications infrastructure company that owns, operates and develops communications sites. Its primary business includes leasing antenna space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data providers, government agencies and municipalities and tenants in a number of other industries. This business is its rental and management operations, which accounted for approximately 98% of its total revenues during the year ended December 31, 2011. In January 2012, the Company merged with and into American Tower REIT, Inc. In October 2013, the Company acquired MIP Tower Holdings LLC. In November2013, NII Holdings, Inc sold 1,483 communications sites in Mexico to American Tower Corporation.
Copied from Website.
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a okay investment. The stock doesnt increase/decrease alot, let alone much at all. This is a investment you have to watch and let the company gain more capital before you invest. Or buy few stocks, your not going to make the money you want to make off this stock.
Abbott Labs
Image borrowed from website.
Stock Graph:
Link to Google Finance Abbott Laboratories Stock Graph
Stock Symbol:
ABT
Stock Exchange:
NYSE
RSS feeds from company:
**Abbott laboratories Corporation News Release - Corporate Press Releases.**
RSS Feeds from other sources:
**New York Times: Abbott Laboratories.**Sector and Industry:
Sector- Financial
Industry-
REIT - Diversified
What they produce:
Copied from Google Finance.
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United States; 30% in Western Europe, Canada, Japan and Australia, and 40% in the economies, including India, China, Russia and Brazil. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. In August 2013, Abbott Laboratories completed its acquisition of OptiMedica Corporation. In August 2013, Abbott Laboratories completed its acquisition of IDEV Technologies.
Current P/E ratio and Competitors P/E:
Abbott laboratories 29.84Johnson & Johnson 19.17
Thermo Fisher Scientific Inc. 31.09
Roche Holding Ltd. 29.84
Dividend Information:
Div & yield 0.22 (2.12%)52 Week High/Low:
$32.75 - $44.20My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a good investment. Even for today, this stock has went from $41.44 to $41.59. This company doesn't have many decreases, the charts all go positive and the business is growing. The company has a good set of business people to run the business and make responsible money making not wasting decisions. Personally, I would recommend this stock to investors looking to have a nice pay day someday in the future when this business gains more capitol.
Actavis
Image borrowed from website.
Stock Graph:
Link to Google finance Actavis stock graph.
Stock Symbol:
ACT
Stock Exchange:
NYSE
RSS Feeds from company:
**Actavis Corporation News Release - Corporate Press Releases**
RSS Feeds from other sources:
**Google Finance: Actavis News**Sector and Industry:
Sector- Health CareIndustry- Drugs (Generic)
What they produce:
Information found at Actavis website.Actavis is a pharmaceutical company that produces drugs. Mostly Generic brands of drugs, but their a major medicine supplier in our country.
Current P/E ratio and Competitors P/E:
Actavis- 375.60Mylan, Inc.- 34.24
Pfizer Inc.- 18.33
Johnson & Johnson- 19.17
Dividend Information:
This company does not pay dividends.Information from Google finance.
52 Week High/Low:
$136.52 - $249.94My Recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a sketchy investment. This is one of those stock that are either doing great and your making money, and the next day the price drops $5.00 a share. It all really depends on health in our country, more sick people, more medicine needed, less sick people, less medicine needed.
Alcoa
Image borrowed from website.
Stock Graph:
Link to Google finance Alcoa stock graph.
Stock Symbol:
AA
Stock Exchange:
NYSE
RSS Feeds from company:
**Alcoa Incorporated News Release - Corporate Press Releases**
RSS Feeds from other sources:
New York TImes: Alcoa RSS FeedsSector & Industry:
Sector- Basic Materials
Industry- Aluminum
What they produce:
Alcoa Inc. (Alcoa) is engaged in lightweight metals, products and solutions. The Company offers its technology and expertise in automotive and aerospace transportation, building and construction, consumer electronics and packaging, defense applications across air, land and sea, and the oil and gas industry. The Company is also a producer of primary aluminum, as well as a miner of bauxite and refiner of alumina. The Company’s segments include Alumina, Primary Metals, Global Rolled Products and Engineered Products and Solutions.
Copied from website.
Current P/E ratio and Competitors P/E:
Alcoa- No P.E because negative earningsNorsk Hydro ASA- No P.E because negative earnings
Alumina Limited- No P.E because negative earnings
Ormet Corp- 0.00
Dividend Information:
Div & yield: 0.03 (0.78%)52 week High/Low:
$8.09 - $17.36
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a sketchy investment. This stock is not really steady, it has its time where all it does is positively go up and you can make a bunch of money, but the next day its down back to $8.00 a share. Its not consistent enough for me to invest in anyway.
Allergan
Image borrowed from website.
Stock Graph:
Link to Google finance Allergan stock graph.
Stock Symbol:
AGN
Stock Exchange:
NYSE
RSS Feeds from company:
**Allergan News Release - Corporate Press Releases**
RSS Feeds from other sources:
New York TImes: Allergan RSS FeedsSector & Industry:
Sector- Health Care
Industry- Drug Manufactures (Other)
What they Produce:
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company’s segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and other prescription and over-the-counter skin care products; and urologic products and the medical devices segment, which produces a range of medical devices, including breast implants for augmentation, revision and reconstructive surgery and tissue expanders; obesity intervention products, and facial aesthetics products. In April 2014, TauTona Group’s subsidiary Aline Aesthetics has completed the sale of its Aline hyaluronic acid (HA) thread technology to Allergan, Inc.
Copied from Website.
Current P/E ratio and Competitors P/E:
Allergan- 43.17Valeant Pharmaceuticals Intl Inc- No P.E because negative earnings
Novartis AG (ADR)- 23.50
Johnson & Johnson- 18.88
Dividend Information:
Div & yield: 0.05 (0.11%)52 week High/Low:
$88.34 - $192.98
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a pretty good investment but not at this moment. The stock history isnt to bad, the 52 week high/low is $88.34 all the way up to $192.98. Thats a good increase for one year, over one hundred dollars. But at the moment the stock isnt looking so good so its best to watch the stock and wait for it, hitting it at the right time for a sure investment.
American Tower Corporation
Image borrowed from website.
Stock Graph:
Link to Google finance American Tower Corp stock graph.
Stock Symbol:
AMT
Stock Exchange:
NYSE
RSS Feeds from company:
**American Tower corp News Release - Corporate Press Releases**
RSS Feeds from other sources:
New York TImes: American Tower corp RSS FeedsSector & Industry:
Sector- Financial
Industry- REIT
What they Produce:
American Tower Corporation is a holding company. The Company conducts its operations through its directly and indirectly owned subsidiaries and joint ventures. It is a wireless and broadcast communications infrastructure company that owns, operates and develops communications sites. Its primary business includes leasing antenna space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data providers, government agencies and municipalities and tenants in a number of other industries. This business is its rental and management operations, which accounted for approximately 98% of its total revenues during the year ended December 31, 2011. In January 2012, the Company merged with and into American Tower REIT, Inc. In October 2013, the Company acquired MIP Tower Holdings LLC. In November2013, NII Holdings, Inc sold 1,483 communications sites in Mexico to American Tower Corporation.
Copied from Website.
Current P/E ratio and Competitors P/E:
American Tower Corp- 53.05Potlatch Corporation- 22.90
Catchmark Timber Trust Inc- No P.E because negative earnings
Crown Castle International Corp.- 207.03
Dividend Information:
Div & yield: 0.36 (1.52%)52 week High/Low:
$72.05 - $99.90
My recommendation:
After analyzing this stock looking at current news from the company and other sources, looking at the P/E ratio compared to competitors, looking at their stock chart, looking at current prices compared to 52 week high/low, and Stock analyst reports, I think this company would be a okay investment. The stock doesnt increase/decrease alot, let alone much at all. This is a investment you have to watch and let the company gain more capital before you invest. Or buy few stocks, your not going to make the money you want to make off this stock.